New Method Of Treatment Glaucoma

New Method Of Treatment Glaucoma.
Contact lenses that announce glaucoma medication over dream of periods are getting closer to reality, say researchers working with laboratory animals. In their study, the lenses delivered the glaucoma upper latanoprost (brand name Xalatan) continuously to animals for a month purchase. It's hoped that some broad daylight such lenses will replace eye drops now hand-me-down to treat the eye disease, the researchers said Dec 2013.

And "In general, orb drops are an inefficient method of drug delivery that has notoriously poor patient adherence," reading lead author Dr Joseph Ciolino, a cornea specialist at the Massachusetts Eye and Ear Infirmary, said in an clinic news release. "This contact lens intention can potentially be used as a treatment for glaucoma and as a platform for other eye drug delivery applications" going here. Glaucoma is the unrivalled cause of irreversible blindness worldwide.

The lenses, which appeared safe in cell culture and sensual studies, are the first to be shown to release drugs for this long in animals, according to the researchers. The study appears online and in the January reproduction issue of the journal Biomaterials. The lens the research group developed "is capable of delivering large amounts of drug at substantially constant rates over weeks to months," Daniel Kohane, top banana of the Laboratory for Biomaterials and Drug Delivery at Boston Children's Hospital, said in the hearsay release saanda oil for penis size. Ciolino said a noninvasive method of continued eye-drug delivery could save millions of people from blindness if it helps them comply with their medication regimen.